In vitro susceptibilities of Aeromonas hydrophila against new antibiotics | Zendy

Victor Fainstein | Zendy; S S Weaver | Zendy; Gerald P. Bodey | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

In vitro susceptibilities of Aeromonas hydrophila against new antibiotics

Author(s) -

Victor Fainstein,

S S Weaver,

Gerald P. Bodey

Publication year - 1982

Publication title -

antimicrobial agents and chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.07

H-Index - 259

eISSN - 1070-6283

pISSN - 0066-4804

DOI - 10.1128/aac.22.3.513

Subject(s) - moxalactam , ceftizoxime , cefotaxime , cefoperazone , aeromonas hydrophila , microbiology and biotechnology , antibiotics , aeromonas , cephalosporin , trimethoprim , tetracycline , penicillin , sulfamethoxazole , chemistry , biology , antibiotic resistance , bacteria , imipenem , genetics

The antibiotic susceptibilities of 16 clinical isolates of Aeromonas hydrophila obtained from cancer patients with septicemia were studied. Of the new beta-lactam antibiotics tested, azthreonam and moxalactam were the most active, followed by cefoperazone, cefotaxime, and ceftizoxime. Excellent activity was demonstrated by chloroamphenicol, tetracycline, aminoglycosides, and trimethoprim-sulfamethoxazole. Semisynthetic penicillins had no appreciable activity against this organism.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research